Invitrogen, Luminex Extend and Expand License | GenomeWeb
NEW YORK, (GenomeWeb News) – Invitrogen and Luminex jointly announced today that they have extended and expanded a licensing agreement for Luminex’s multiplex technology and systems.
 
The new license extends the lifetime of the license and expands Invitrogen’s rights to include Luminex’s next-generation multiplex detection platforms. The firms did not disclose the length of or terms of the agreement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.